These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8137681)

  • 41. The incidence of nephropathy in type 1 diabetic patients with proliferative retinopathy: a 10-year follow-up study.
    Lövestam-Adrian M; Agardh E; Agardh CD
    Diabetes Res Clin Pract; 1998 Jan; 39(1):11-7. PubMed ID: 9597369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Microalbuminuria Collaborative Study Group, United Kingdom.
    BMJ; 1995 Oct; 311(7011):973-7. PubMed ID: 7580637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microalbuminuria and clinical correlates in black African patients with type 2 diabetes.
    Adetunji OR; Adeleye JO; Agada NO; Salako BL
    West Afr J Med; 2006; 25(4):279-83. PubMed ID: 17402516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes.
    Parving HH; Hommel E; Mathiesen E; Skøtt P; Edsberg B; Bahnsen M; Lauritzen M; Hougaard P; Lauritzen E
    Br Med J (Clin Res Ed); 1988 Jan; 296(6616):156-60. PubMed ID: 3122980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients.
    Dahlquist G; Stattin EL; Rudberg S
    Nephrol Dial Transplant; 2001 Jul; 16(7):1382-6. PubMed ID: 11427629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion.
    Lane PH; Steffes MW; Mauer SM
    Diabetes; 1992 May; 41(5):581-6. PubMed ID: 1568527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is a random urinary albumin concentration a useful screening test in insulin-treated diabetic patients?
    Beatty OL; Ritchie CM; Hadden DR; Kennedy L; Bell PM; Atkinson AB
    Ir J Med Sci; 1994 Sep; 163(9):406-9. PubMed ID: 7982765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Microalbuminuria as risk factor for nephropathy in children with insulin-dependent diabetes mellitus].
    Baak MA; Odink RJ; Delemarre-van de Waal HA
    Ned Tijdschr Geneeskd; 1993 Jul; 137(27):1349-52. PubMed ID: 8350940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cigarette smoking and urinary albumin excretion in insulin-treated diabetics without manifest nephropathy.
    Ekberg G; Grefberg N; Larsson LO
    J Intern Med; 1991 Nov; 230(5):435-42. PubMed ID: 1940779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prevalence of microalbuminuria in diabetes: a study from north India.
    Gupta DK; Verma LK; Khosla PK; Dash SC
    Diabetes Res Clin Pract; 1991 May; 12(2):125-8. PubMed ID: 1879303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
    Ansquer JC; Foucher C; Rattier S; Taskinen MR; Steiner G;
    Am J Kidney Dis; 2005 Mar; 45(3):485-93. PubMed ID: 15754270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients.
    Tanaka Y; Atsumi Y; Matsuoka K; Onuma T; Tohjima T; Kawamori R
    Diabetes Care; 1998 Jan; 21(1):116-20. PubMed ID: 9538981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Microalbuminuria Collaborative Study Group, United Kingdom.
    BMJ; 1993 May; 306(6887):1235-9. PubMed ID: 8499853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients.
    Poulsen PL; Hansen KW; Mogensen CE
    Diabetes; 1994 Oct; 43(10):1248-53. PubMed ID: 7926296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diurnal blood pressure pattern may predict the increase of urinary albumin excretion in normotensive normoalbuminuric type 1 diabetes mellitus patients.
    Lengyel Z; Rosivall L; Németh C; Tóth LK; Nagy V; Mihály M; Kammerer L; Vörös P
    Diabetes Res Clin Pract; 2003 Dec; 62(3):159-67. PubMed ID: 14625130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal study of urinary albumin excretion in young diabetic patients--Wessex Diabetic Nephropathy Project.
    Twyman S; Rowe D; Mansell P; Schapira D; Betts P; Leatherdale B;
    Diabet Med; 2001 May; 18(5):402-8. PubMed ID: 11472452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients.
    Poulsen PL; Ebbehøj E; Hansen KW; Mogensen CE
    Diabetologia; 1997 Jun; 40(6):718-25. PubMed ID: 9222653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regression of microalbuminuria in type 1 diabetic patients: results of a sequential intervention with improved metabolic control and ACE inhibitors.
    Vilarrasa N; Soler J; Montanya E
    Acta Diabetol; 2005 Jun; 42(2):87-94. PubMed ID: 15944842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment - systematic review and modelling of progression and cost-effectiveness.
    Farmer AJ; Stevens R; Hirst J; Lung T; Oke J; Clarke P; Glasziou P; Neil A; Dunger D; M Colhoun H; Pugh C; Wong G; Perera R; Shine B
    Health Technol Assess; 2014 Feb; 18(14):1-128. PubMed ID: 24576414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.